about
Who pays for health care in China? The case of Heilongjiang province.A meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality.Who benefits from government healthcare subsidies? An assessment of the equity of healthcare benefits distribution in ChinaWho benefited from the New Rural Cooperative Medical System in China? A case study on Anhui Province.Workplace Injuries in Thoroughbred Racing: An Analysis of Insurance Payments and Injuries amongst Jockeys in Australia from 2002 to 2010.Assessing equity in benefit distribution of government health subsidy in 2012 across East China: benefit incidence analysis.Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence.Has equity in government subsidy on healthcare improved in China? Evidence from the China's National Health Services Survey.How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review.A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures.A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions.A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis.A Systematic Review of Cost-of-Illness Studies of Multimorbidity.Establishing benchmark EQ-5D-3L population health state utilities and identifying their correlates in Gansu Province, China.Investigating the costs of major and minor cycling crashes in Tasmania, Australia.Residual lifetime and 10 year absolute risks of osteoporotic fractures in Chinese men and women.Australian insurance costs of jockeys injured in a race-day fall.Projection of osteoporosis-related fractures and costs in China: 2010-2050.Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.Challenges to the Chinese health insurance system: users' and service providers' perspectives.Accident rates amongst regular bicycle riders in Tasmania, Australia.Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model.Improving equity in health care financing in China during the progression towards Universal Health Coverage.The Associations of Multimorbidity With Health-Related Productivity Loss in a Large and Diverse Public Sector Setting: A Cross-Sectional Survey.Social health insurance, healthcare utilization, and costs in middle-aged and elderly community-dwelling adults in China.Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia.Is outpatient care benefit distribution of government healthcare subsidies equitable in rural ethnic minority areas of China? Results from cross-sectional studies in 2010 and 2013.A Global Social Media Survey of Attitudes to Human Genome Editing.Cost-effectiveness of strain-targeted cardioprotection for prevention of chemotherapy-induced cardiotoxicity.Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study.Forgone care among middle aged and elderly with chronic diseases in China: evidence from the China Health and Retirement Longitudinal Study Baseline Survey.Hospital length of stay variation and comorbidity of mental illness: a retrospective study of five common chronic medical conditions.A Need for Better Understanding Is the Major Determinant for Public Perceptions of Human Gene EditingComputer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood ChallengeThe role of intergenerational educational mobility and household wealth in adult obesity: Evidence from Wave 2 of the World Health Organization's Study on global AGEing and adult healthDid expansion of health insurance coverage reduce horizontal inequity in healthcare finance? A decomposition analysis for ChinaMicrosimulation model for the health economic evaluation of osteoporosis interventions: study protocolAnnual transition probabilities of overweight and obesity in older adults: Evidence from World Health Organization Study on global AGEing and adult healthUsing strategic price negotiations to contain costs and expand access to medicines in ChinaEvaluation of the Association Between Health State Utilities and Obesity in Sub-Saharan Africa: Evidence From World Health Organization Study on Global AGEing and Adult Health Wave 2
P50
Q34278334-4D6D32DE-7EC6-49FE-B2E7-2C8248263B68Q34576440-D14E2B24-A016-42C3-B3BC-5717A3832028Q35185911-CB5BD4B1-4E98-4406-ABF5-4B083089D0C9Q36041113-28461621-10BD-447E-9968-3001D2BABA9BQ36138926-BE191600-7FD7-4CEE-87A7-551644284459Q36485595-1B80F8BF-A6DD-464C-BBB5-DC0B08E9FB15Q36763643-19E73F11-4E87-4951-8F11-5AAB9C31059EQ37576539-2CFAD11B-C0CD-4F70-99A5-D754FF007394Q37639785-7832C1A9-B22B-42E7-97A6-DFAA583FD1E3Q38155095-662825E0-C9B9-4C02-AECD-8882EEA6A318Q38190449-3C0E76EF-52BB-4659-B912-4DA44BE1D11BQ38563037-A945596A-2A23-4F7D-BFB7-E7942276A3CDQ38600977-48A64CA1-20F6-42B4-B6E9-12D67F45CDB2Q38737063-1D4FD7C4-8063-47C0-83AE-8883C57883A2Q40785488-D1065244-07D0-483F-BE6A-F72BFD718121Q41103937-9E61B473-C3DE-40E1-A374-8421CDD3CDA1Q41123039-6247F083-E42D-4DD5-80AB-53846ED27B55Q41243465-357BB70B-1DD4-488E-99F6-6BEAD584D46DQ41611263-0355F585-0969-4740-8C53-2DDCC8D06BABQ42876490-B49E6D9B-D645-4FBA-B263-86FD02EC441AQ44605203-0293E81B-8448-43C9-BB8C-200D477C1777Q47141756-DB0C1B72-D5CA-48FE-BD1E-0F7FD817AA70Q47150798-3533EF7D-7701-48C6-BFC0-8A5C45CB616FQ47376199-9BD73408-1119-4EAE-A069-3190C7421EECQ48113502-AB352278-89B6-444B-8211-816070C37299Q48883719-1A92235B-8827-4D07-A55F-B117F3679418Q50069381-D9C60383-81FA-498E-9AAD-2DCC3E3100EFQ50212970-750A8DA9-EF43-4F8E-8F5C-04CF40C455C1Q50862950-5153450E-7058-4288-8893-1E0ECF8FCB07Q50886771-3B038283-026F-4DC9-A84E-F0D7E88C82E0Q51739098-24AD1649-7B28-4532-84C4-4F0844936B3FQ55424386-E2A3E22F-819C-4223-9FD7-3F8E7BB0FAFDQ57036762-8C9F7E9E-00A0-4877-8972-A3E57C9643B5Q58477928-1A673C04-FBEC-442C-83EB-02B3FBBBE4FBQ60914096-AF3C9B52-92E3-44C1-8F69-24F41353A2C7Q61798970-EA0B3F2D-73F6-4671-AB77-063E1A6618BAQ64236287-5B1A8CA4-30F9-41B3-AC15-8D45FCC4B0BCQ89527963-ED136C94-93DE-4A81-9DB6-4D8BD706603FQ90056099-BAB119AC-D69C-4D3D-9A1D-15BCF6C2B7E0Q90067280-0A5A5081-C28F-4CBC-A806-A3B4011FB166
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
L Si
@ast
L Si
@en
L Si
@es
L Si
@nl
L Si
@sl
type
label
L Si
@ast
L Si
@en
L Si
@es
L Si
@nl
L Si
@sl
prefLabel
L Si
@ast
L Si
@en
L Si
@es
L Si
@nl
L Si
@sl
P106
P1153
55913362600
P31
P496
0000-0002-3044-170X